Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Towards a glutamate hypothesis of depression
Gerard Sanacora, Giulia Treccani, Maurizio Popoli
Neuropharmacology (2011) Vol. 62, Iss. 1, pp. 63-77
Open Access | Times Cited: 948

Showing 26-50 of 948 citing articles:

Genome-wide analysis of over 106 000 individuals identifies 9 neuroticism-associated loci
Daniel J. Smıth, Valentina Escott‐Price, Gail Davies, et al.
Molecular Psychiatry (2016) Vol. 21, Iss. 6, pp. 749-757
Open Access | Times Cited: 261
Is serotonin an upper or a downer? The evolution of the serotonergic system and its role in depression and the antidepressant response
Paul W. Andrews, Aadil Bharwani, Kyuwon R. Lee, et al.
Neuroscience & Biobehavioral Reviews (2015) Vol. 51, pp. 164-188
Closed Access | Times Cited: 248
Treatment resistance in psychiatry: state of the art and new directions
Oliver Howes, Michael E. Thase, Toby Pillinger
Molecular Psychiatry (2021) Vol. 27, Iss. 1, pp. 58-72
Open Access | Times Cited: 242
Sex differences in glutamate receptor gene expression in major depression and suicide
Aidan Gray, Thomas M. Hyde, Amy Deep–Soboslay, et al.
Molecular Psychiatry (2015) Vol. 20, Iss. 9, pp. 1057-1068
Open Access | Times Cited: 238
Neuroplasticity Underlying the Comorbidity of Pain and Depression
Lisa Doan, Toby Manders, Jing Wang
Neural Plasticity (2015) Vol. 2015, pp. 1-16
Open Access | Times Cited: 231
Blood microRNA changes in depressed patients during antidepressant treatment
Luisella Bocchio‐Chiavetto, Elisabetta Maffioletti, Paola Bettinsoli, et al.
European Neuropsychopharmacology (2012) Vol. 23, Iss. 7, pp. 602-611
Closed Access | Times Cited: 227
Conceptual convergence: increased inflammation is associated with increased basal ganglia glutamate in patients with major depression
Ebrahim Haroon, Candace C. Fleischer, Jennifer C. Felger, et al.
Molecular Psychiatry (2016) Vol. 21, Iss. 10, pp. 1351-1357
Open Access | Times Cited: 226
Lanicemine: a low-trapping NMDA channel blocker produces sustained antidepressant efficacy with minimal psychotomimetic adverse effects
Gerard Sanacora, Mark A. Smith, Sanjeev Pathak, et al.
Molecular Psychiatry (2013) Vol. 19, Iss. 9, pp. 978-985
Open Access | Times Cited: 221
From Serotonin to Neuroplasticity: Evolvement of Theories for Major Depressive Disorder
Bangshan Liu, Jin Liu, Mi Wang, et al.
Frontiers in Cellular Neuroscience (2017) Vol. 11
Open Access | Times Cited: 221
Density of GFAP-immunoreactive astrocytes is decreased in left hippocampi in major depressive disorder
Justin Cobb, Kathy E. O’Neill, Joel S. Milner, et al.
Neuroscience (2015) Vol. 316, pp. 209-220
Open Access | Times Cited: 220
Emerging mechanisms and treatments for depression beyond SSRIs and SNRIs
Elena Dale, Benny Bang‐Andersen, Connie Sánchez
Biochemical Pharmacology (2015) Vol. 95, Iss. 2, pp. 81-97
Open Access | Times Cited: 214
Stratification of astrocytes in healthy and diseased brain
Alexei Verkhratsky, Robert Zorec, Vladimir Parpura
Brain Pathology (2017) Vol. 27, Iss. 5, pp. 629-644
Open Access | Times Cited: 213
Evidence for a Dysregulated Immune System in the Etiology of Psychiatric Disorders
Sinead M. Gibney, Hemmo A. Drexhage
Journal of Neuroimmune Pharmacology (2013) Vol. 8, Iss. 4, pp. 900-920
Closed Access | Times Cited: 212
The neuropsychopharmacology of cannabis: A review of human imaging studies
Michael Bloomfield, Chandni Hindocha, Sebastian F Green, et al.
Pharmacology & Therapeutics (2018) Vol. 195, pp. 132-161
Open Access | Times Cited: 210
Neural correlates of change in major depressive disorder anhedonia following open-label ketamine
Níall Lally, Allison C. Nugent, David A. Luckenbaugh, et al.
Journal of Psychopharmacology (2015) Vol. 29, Iss. 5, pp. 596-607
Open Access | Times Cited: 208
Emerging Role for Nucleus Accumbens Medium Spiny Neuron Subtypes in Depression
T. Chase Francis, Mary Kay Lobo
Biological Psychiatry (2016) Vol. 81, Iss. 8, pp. 645-653
Open Access | Times Cited: 202
Ovarian Hormone Fluctuation, Neurosteroids, and HPA Axis Dysregulation in Perimenopausal Depression: A Novel Heuristic Model
Jennifer L. Gordon, Susan S. Girdler, Samantha Meltzer‐Brody, et al.
American Journal of Psychiatry (2015) Vol. 172, Iss. 3, pp. 227-236
Open Access | Times Cited: 199
The neurobiology of depression, ketamine and rapid-acting antidepressants: Is it glutamate inhibition or activation?
Chadi G. Abdallah, Gerard Sanacora, Ronald S. Duman, et al.
Pharmacology & Therapeutics (2018) Vol. 190, pp. 148-158
Open Access | Times Cited: 198
Chronic Stress Increases Prefrontal Inhibition: A Mechanism for Stress-Induced Prefrontal Dysfunction
Jessica M. McKlveen, Rachel Morano, Maureen Fitzgerald, et al.
Biological Psychiatry (2016) Vol. 80, Iss. 10, pp. 754-764
Open Access | Times Cited: 197
An astroglial basis of major depressive disorder? An overview
Qian Wang, Wei Jie, Jihong Liu, et al.
Glia (2017) Vol. 65, Iss. 8, pp. 1227-1250
Closed Access | Times Cited: 190
Cellular and molecular basis for stress-induced depression
J-S Seo, Jing Wei, Qin Li, et al.
Molecular Psychiatry (2016) Vol. 22, Iss. 10, pp. 1440-1447
Open Access | Times Cited: 187
Differences in excitatory and inhibitory neurotransmitter levels between depressed patients and healthy controls: A systematic review and meta-analysis
Kate Godfrey, Abby C. Gardner, Sarah Kwon, et al.
Journal of Psychiatric Research (2018) Vol. 105, pp. 33-44
Closed Access | Times Cited: 167
Ketamine as an antidepressant: overview of its mechanisms of action and potential predictive biomarkers
Dmitriy Matveychuk, Rejish K. Thomas, Jennifer Swainson, et al.
Therapeutic Advances in Psychopharmacology (2020) Vol. 10
Open Access | Times Cited: 161
Prefrontal excitatory/inhibitory balance in stress and emotional disorders: Evidence for over-inhibition
Chloe E. Page, Laurence Coutellier
Neuroscience & Biobehavioral Reviews (2019) Vol. 105, pp. 39-51
Open Access | Times Cited: 158
Fast-acting antidepressant activity of ketamine: highlights on brain serotonin, glutamate, and GABA neurotransmission in preclinical studies
Thu Ha Pham, Alain M. Gardier
Pharmacology & Therapeutics (2019) Vol. 199, pp. 58-90
Open Access | Times Cited: 154

Scroll to top